Literature DB >> 8268049

Femoral head necrosis and osteopenia in stroke-prone spontaneously hypertensive rats (SHRSPs).

S Naito1, M Ito, I Sekine, M Ito, T Hirano, K Iwasaki, M Niwa.   

Abstract

Necrosis of the femoral head and osteopenia were examined histopathologically in stroke-prone spontaneously hypertensive rats (SHRSPs) aged 6 to 36 weeks and compared with that of spontaneously hypertensive rats (SHRs) and Wistar-Kyoto rats (WKYs). Avascular necrosis of the femoral head was frequently observed, mainly in the young SHRSPs and SHRs (about 8 to 15 weeks of age). SHRSPs had the highest incidence of femoral head necrosis among the three strains. This necrotic change in the femoral head was considered to be secondary ischemia induced by angiospasm or arteriosclerosis, similar to the disorders observed in the brain, kidney, and heart in SHRSPs. However, the complication occurred in spite of treatment with antihypertensive agents (ACE inhibitor: enalapril, spirapril) even though other ischemic disorders such as brain hemorrhage and renal infarction were prevented, indicating that the femoral head necrosis in SHRSPs was not due to hypertensive complications induced by angiospasm or arteriosclerosis. Bone mineral density (BMD) of the femoral bone was significantly lower in SHRSPs, and the femoral heads in this strain were the most easily deformed by loads applied during compression tests. Histopathologically, the infarctions were encountered on the lateral side of the epiphysis, but no thrombi were observed. The lateral side of the epiphysis is the anatomic site where the weight load is greatest and the site where the nutritive artery enters. Our results strongly suggest that the coexistence of vulnerable bone matrix and physical weight load to the nutritive artery plays a crucial role in the occurrence of femoral head necrosis in SHRSPs, whether based on generalized or localized osteopenia.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8268049     DOI: 10.1016/8756-3282(93)90206-p

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  7 in total

1.  Scanning and transmission electron microscopic observation of femoral head feeding vessels in stroke-prone spontaneously hypertensive rats.

Authors:  Masahide Amemiya; Takashi Yashiro; Motoshi Kikuchi; Tom Kouki; Sueo Nakama; Yuichi Hoshino
Journal:  Med Mol Morphol       Date:  2011-09-16       Impact factor: 2.309

2.  Involvement of platelet activation in experimental osteonecrosis in rabbits.

Authors:  K Masuhara; K Nakata; S Yamasaki; H Miki; H Yoshikawa
Journal:  Int J Exp Pathol       Date:  2001-10       Impact factor: 1.925

3.  Soluble epoxide hydrolase inhibitor can protect the femoral head against tobacco smoke exposure-induced osteonecrosis in spontaneously hypertensive rats.

Authors:  Jingyi Xu; Xing Qiu; Gary Yu; Maria Ly; Jun Yang; Rona M Silva; Xun Zhang; Mang Yu; Yinong Wang; Bruce Hammock; Kent E Pinkerton; Dewei Zhao
Journal:  Toxicology       Date:  2021-11-18       Impact factor: 4.571

4.  Primary epiphyseal arteriopathy in a mouse model of steroid-induced osteonecrosis.

Authors:  Laura J Janke; Chengcheng Liu; Peter Vogel; Jitesh Kawedia; Kelli L Boyd; Amy J Funk; Mary V Relling
Journal:  Am J Pathol       Date:  2013-05-11       Impact factor: 4.307

5.  Study of the intraosseous vessels of the femoral head in patients with fractures of the femoral neck or osteoarthritis of the hip.

Authors:  M Laroche; I Ludot; M Thiechart; J Arlet; M Pieraggi; P Chiron; L Moulinier; A Cantagrel; J Puget; G Utheza
Journal:  Osteoporos Int       Date:  1995       Impact factor: 4.507

6.  An animal model of femoral head osteonecrosis induced by a single injection of absolute alcohol: an experimental study.

Authors:  Zhen-Hong Zhu; You-Shui Gao; Shi-Hua Luo; Bing-Fang Zeng; Chang-Qing Zhang
Journal:  Med Sci Monit       Date:  2011-04

7.  Altered cellular kinetics in the growth plate of the femoral head of spontaneously hypertensive rats.

Authors:  Hoon Park; Sun Young Kong; Hyun Woo Kim
Journal:  Yonsei Med J       Date:  2012-05       Impact factor: 2.759

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.